Clinical assessment of immunohistochemistry, digital image quantification and AQUA for breast biomarkers ER, PR, HER2 and Ki67

被引：0
|
作者：
Gandy, M. [1 ]
Stone, K. [1 ]
Allen, D. [1 ]
Jones, P. [1 ]
Miller, K. [1 ]
Hamoudi, R. [1 ]
Falzon, M. [1 ]
Wells, C. [1 ]
机构：
[1] UCL, Dept Tissue & Energy, London WC1E 6BT, England
来源：
VIRCHOWS ARCHIV | 2014年 / 465卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-03-117
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [1] Development & Validation of an AI-supported Workflow for Clinical Scoring of HER2, ER, PR & Ki67 Immunohistochemistry in Breast Cancer Tissue
    Lodge, Meredith
    Ironside, Alastair
    Graham, Ashley
    Polonia, Antonio
    Reinhard, Stefan
    Solass, Wiebke
    Zlobec, Inti
    Caie, Peter
    CANCER RESEARCH, 2024, 84 (09)
  • [2] Utility of the Combination of Digital Pathology and Artificial Intelligence in the Quantification of ER, PR, HER2, and Ki67: Benefits in Clinical Practice and Remaining Challenges
    Colon, Eugenia
    Kis, Lorand
    Farkas, Andrea
    Dolapcsiev, Karoly
    Forsberg, Pehr
    Andersson, Emilia
    LABORATORY INVESTIGATION, 2024, 104 (03) : S138 - S139
  • [3] Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
    Lili Chen
    Yanyang Chen
    Zhongpeng Xie
    Jiao Luo
    Yuefeng Wang
    Jianwen Zhou
    Leilei Huang
    Hongxia Li
    Linhai Wang
    Pei Liu
    Man Shu
    Wenhui Zhang
    Zunfu Ke
    Breast Cancer Research and Treatment, 2022, 194 : 517 - 529
  • [4] Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
    Chen, Lili
    Chen, Yanyang
    Xie, Zhongpeng
    Luo, Jiao
    Wang, Yuefeng
    Zhou, Jianwen
    Huang, Leilei
    Li, Hongxia
    Wang, Linhai
    Liu, Pei
    Shu, Man
    Zhang, Wenhui
    Ke, Zunfu
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (03) : 517 - 529
  • [5] The Correlation of Nottingham Prognostic Index with Immunoexpression of ER, PR, HER2, and Ki67 in Breast Cancer Tissue
    Ruangpratheep, Chetana
    Piyaisrakul, Supakorn
    ANNALS OF ONCOLOGY, 2019, 30 : 93 - 93
  • [6] Comparison of ER, PR, HER2 and Ki67 expression by MammaTyper® RT-qPCR and immunohistochemistry (IHC) on needle core biopsies of breast cancer
    Shaaban, A.
    Badr, N.
    Zaakouk, M.
    Kearns, D.
    Kong, A.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S87 - S88
  • [7] Quantification of ER, PR, and Ki67 in Breast Cancer Using Image Analysis Software: A Validation Study
    Han, Rachel
    Wen, Hannah
    Giri, Dilip
    Kuba, Maria
    Hanna, Matthew
    LABORATORY INVESTIGATION, 2024, 104 (03) : S169 - S171
  • [8] Digital quantification of Ki67 in breast cancer
    Rosario Taco, M. D.
    Soler, T.
    Petit, A.
    Perez, X.
    Falo, C.
    Matias-Guiu, X.
    VIRCHOWS ARCHIV, 2016, 469 : S62 - S62
  • [9] Validating the APIS Breast Cancer Subtyping Kit: mRNA Expression of ER, PR, HER2, and Ki67 Compared to Immunohistochemistry in 374 Breast Cancer Core Needle Biopsies
    Gasior, A.
    Wegscheider, A.
    Kramme, I.
    Behr, M.
    Howard, K.
    Gorniak, J.
    Rollinson, S.
    Voss, A.
    Ulm, B.
    Niendorf, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S140 - S140
  • [10] ER, PR, Her2, and Ki-67 Expression in Male and Female Breast Cancer
    Lockyer, M. G.
    Martinez-Blanco, E.
    Verstovsek, G.
    Bedrosian, I.
    Albarracin, C.
    Rosen, D.
    LABORATORY INVESTIGATION, 2013, 93 : 54A - 55A
12345